Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activity.
暂无分享,去创建一个
Wolfgang Sippl | Manfred Jung | Alexander-Thomas Hauser | Eric Metzger | Roland Schüle | Martin Pippel | W. Sippl | M. Barton | R. Schüle | T. Yiu | M. Jung | Luca Carlino | Alexander-Thomas Hauser | E. Metzger | M. Pippel | Johannes Schulz-Fincke | Martin Schmitt | Dominica Willmann | D. Willmann | Luca Carlino | Martin L Schmitt | Johannes Schulz-Fincke | Teresa Yiu | Michelle Barton
[1] A. Ganesan,et al. Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors. , 2011, Bioorganic & medicinal chemistry.
[2] Z. Otwinowski,et al. Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase. , 2006, Molecular cell.
[3] S. Wetzel,et al. Impairment of prostate cancer cell growth by a selective and reversible lysine‐specific demethylase 1 inhibitor , 2012, International journal of cancer.
[4] Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells , 2012, Amino Acids.
[5] A. Giannis,et al. Epigenetics--an epicenter of gene regulation: histones and histone-modifying enzymes. , 2005, Angewandte Chemie.
[6] S. Baylin,et al. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes , 2007, Proceedings of the National Academy of Sciences.
[7] Min Gyu Lee,et al. Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. , 2006, Chemistry & biology.
[8] Takayoshi Suzuki,et al. Lysine demethylases inhibitors. , 2011, Journal of medicinal chemistry.
[9] Bing Li,et al. The Role of Chromatin during Transcription , 2007, Cell.
[10] Makoto Hasegawa,et al. Identification of cell-active lysine specific demethylase 1-selective inhibitors. , 2009, Journal of the American Chemical Society.
[11] T. Umehara,et al. Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A. , 2008, Biochemical and biophysical research communications.
[12] P. Cole,et al. A mechanism-based inactivator for histone demethylase LSD1. , 2006, Journal of the American Chemical Society.
[13] P. Cole,et al. LSD1 and the chemistry of histone demethylation. , 2007, Current opinion in chemical biology.
[14] M. Machius,et al. Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine. , 2007, Biochemistry.
[15] A. Mai,et al. Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2. , 2010, Journal of the American Chemical Society.
[16] D. Ward,et al. Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties. , 2011, Cancer research.
[17] A. Mai,et al. Screening Assays for Epigenetic Targets Using Native Histones as Substrates , 2012, Journal of biomolecular screening.
[18] F. Forneris,et al. Structural Basis of LSD1-CoREST Selectivity in Histone H3 Recognition* , 2007, Journal of Biological Chemistry.
[19] André Hoelz,et al. Crystal structure and mechanism of human lysine-specific demethylase-1 , 2006, Nature Structural &Molecular Biology.
[20] M. Machius,et al. Structural basis of histone demethylation by LSD1 revealed by suicide inactivation , 2007, Nature Structural &Molecular Biology.
[21] Yong Chen,et al. Crystal structure of human histone lysine-specific demethylase 1 (LSD1) , 2006, Proceedings of the National Academy of Sciences.
[22] M. Fraaije,et al. Flavoenzymes: diverse catalysts with recurrent features. , 2000, Trends in biochemical sciences.
[23] Antoine H. F. M. Peters,et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription , 2005, Nature.
[24] T. Umehara,et al. Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1 . , 2010, Biochemistry.